Found 5 matching trials
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) PHASE2 Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) PHASE2 Daprodustat administration has the potential, by virtue of increasing hypox...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) PHASE3 The purpose of this multi-center study in non-dialysis participants with an...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Daprodustat Bioequivalence and Food Effect Study PHASE1 This is two-way crossover study to compare pharmacokinetic (PK) of daprodus...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) PHASE1 Study to Assess the Pharmacokinetics of GSK1278863A Coadministered with a H...
Show More Location
GSK Investigational Site
Learn More & Join Trial